#0002 - Ancient Ayurveda For The Modern World, Renowned Ashtavaidyan Ravi Mooss

https://podcasters.spotify.com/pod/show/auraneuralgiaShow more

00:00 - Introduction To Ashtavaidyan Ravi Mooss, Ayurveda and Panchakarma
06:58 - A Deeper Look Into Ayurveda
16:54 - The Effects of Ayurveda on COVID-19
23:21 - The Effects of What You Consume
36:01 - What is a Male, a Female & Transgender?
53:01 - Pregnancy, Abortion & Love
01:12:26 - Races of Human Beings & The Effects of Living Abroad

Episode notes/references:

https://mooss.com/about-us/

Ashtavaidyan E.T Ravi Mooss, BAMS
.He was born in 1974 as the son of E.T.Divakaran Mooss. He took his BAMS degree in Ayurveda from The Tamilnadu Dr.MGR Medical University Chennai.Currently He is Managing Director of Aatma Ayurvedic Pvt Ltd, Anandapuram.

Ayurveda is the science and Art of living life in a manner useful to society. It has for its objects the preservation of health in the healthy and the restoration of health to the diseased. The word Veda in Ayurveda has been taken by all authorities to imply that it is both a part of and addendum to the great Vedas which have also been admitted by all savants of the West as “the oldest literature of the World”.

Ashtavaidyan E.T Divakaran Mooss
He was born in 1943 as the son of Late E.T.Ravi Mooss. He studied Ayurveda from his uncle Vayaskara N.S.Mooss. He is the founder of Vaidyaraj Oushadhasala, Anandapuram. also a Chief consulting Physician of Vedic Approach to Health of Maharishi Vedic University,The Netherlands. Chairman of Aatma Ayurvedic Pvt Ltd

https://ashtamgam.org/patrons/

Ashtavaidyan Brahmasree E.T.Divakaran Mooss is known as one who maintains the tradition and authenticity of Ayurveda. He is a man with boundless professional experience and is optimistic in his approach. These are his capital contribution to the growth of Ayurveda in Kerala and in the western countries. His Holiness Maharishi Mahesh Yogi appointed Ashtavaidyan Brahmasree E.T.Divakaran Mooss as the chief physician and project consultant of 120 projects world wide.He was honoured with the title Rajavaidya which means the royal physician from Maharishi Mahesh Yogi in 1997. For the successful completion of the assigned projects Ashtavaidyan Brahmasree E.T.Divakaran Mooss used to travel widely in USA, Belgium, Holland and Germany. He returned home to settle down in year 2000 after 6years of his valuable services to Maharishi Vedic University.
Today, he is acting as the chief advisor to Maharishi Ayurvedic University, Iowa, USA where world-wide co-ordination of Ayurvedic projects is done. He was a board member to the Faculty of Ayurvedic studies in the University of Calicut and the Advisory Member to the Indian System of Medicines –Kerala State. Ashtavaidyan Brahmasree E.T.Divakaran Mooss, a simple man conscious of his social responsibilities has always been in the forefront of social and cultural activities. He is the chairman and chief physician of Ashtavaidyan Thaikkattu Mooss. Aatma Ayurvedic Private Ltd., also a chief consulting physician of Keraleeya Ayurveda Samajam Shoranur, PNNM Ayurveda college Cheruthututhy. Received many awards such as Vaidyashtreshta from Bharateeya Ayurveda Paramparya Vaidya Federation, Ayurveda Puraskaram from Guruvayur Samhita Trust etc.

https://en.m.wikipedia.org/wiki/Ashtavaidya

Also check out:

https://www.positivehealth.com/article/ayurveda/ayurveda-in-the-nhs

https://www.frontiersin.org/articles/10.3389/fpubh.2021.732523/full?utm_source=F-NTF&utm_medium=EMLX&utm_campaign=PRD_FEOPS_20170000_ARTICLE

“We have found that such a systematized approach facilitated the delivery of Ayurvedic medicines to Covid-19 quarantined individuals and facilitated the collection and dissemination of data. The Amritham program reached out to 25.7% of quarantined individuals in Kerala from 21 May 2020 to 8 July 2020. Further, only 0.34% of these individuals tested positive for SARS-CoV-2 infection. These individuals later recovered without developing any severe complications or Covid sequelae. However, a detailed analysis has not been done to assess the impact of other co-morbidities and pre-existing health conditions on the general health outcome of quarantined individuals.”
 
 
 
“Recent literature has shown that systematic and integrative use of traditional medicine and conventional medicine offered better clinical outcomes in China with no adverse drug reactions and prevented deterioration of the disease (46–48). Similar findings are also available from India (49, 50). In-silico and preclinical studies on several medicinal plants included in Ayurvedic protocols against various stages of SARS-CoV-2 infection also yielded significant results (51, 52). Furthermore, attempts to establish clinical utility of Ayurvedic formulations are also reflected in the clinical trial registry of India in which a considerable proportion of trials had registered with Ayurvedic drugs in COVID-19 (53, 54).”

https://pubmed.ncbi.nlm.nih.gov/34055580/
 
“Results: Primary outcome of this study was the symptomatic relief from COVID-19. Data collected over a period of two months, showed that more patients exhibited symptomatic relief in Ayur goup (83.33 %) than in the AlloAyur group (48.78 %) within the first 13 days of treatment. No visible adverse effects were observed. This indicated faster and safe symptomatic resolution among those treated with Ayurvedic medicines alone.”

https://pubmed.ncbi.nlm.nih.gov/33596494/
 
Results: By day 3, 71.1 % and 50.0 % patients recovered in the treatment and placebo groups, respectively. Treatment group witnessed 100 % recovery by day 7, while it was 60.0 % in the placebo group. Average fold changes in serum levels of hs-CRP, IL-6 and TNF-α in treatment group were respectively, 12.4, 2.5 and 20 times lesser than those in the placebo group at day 7. There was 40 % absolute reduction in the risk of delayed recovery from infection in the treatment group.